Real-time PCR for pharmacodynamic studies of Chlamydia trachomatis
- 30 June 2005
- journal article
- Published by Elsevier in Journal of Microbiological Methods
- Vol. 61 (3) , 361-367
- https://doi.org/10.1016/j.mimet.2004.12.015
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Chlamydial Persistence: beyond the Biphasic ParadigmInfection and Immunity, 2004
- Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problemsJournal of Molecular Endocrinology, 2002
- Effects of Azithromycin and Rifampin onChlamydia trachomatisInfection In VitroAntimicrobial Agents and Chemotherapy, 2001
- Persistence ofChlamydia trachomatisIs Induced by Ciprofloxacin and Ofloxacin In VitroAntimicrobial Agents and Chemotherapy, 2000
- Evidence for Long‐Term Cervical Persistence ofChlamydia trachomatisbyomp1GenotypingThe Journal of Infectious Diseases, 2000
- Chlamydia trachomatis infection: incidence, health costs and prospects for vaccine developmentJournal of Reproductive Immunology, 2000
- In Vitro Pharmacodynamics of the New Ketolides HMR 3004 and HMR 3647 (Telithromycin) against Chlamydia pneumoniaeAntimicrobial Agents and Chemotherapy, 2000
- Antimicrobial Susceptibility Testing of Chlamydia trachomatis Using a Reverse Transcriptase PCR-Based MethodAntimicrobial Agents and Chemotherapy, 1999
- Sequencing of Gyrase and Topoisomerase IV Quinolone-Resistance-Determining Regions of Chlamydia trachomatis and Characterization of Quinolone-Resistant Mutants Obtained In VitroAntimicrobial Agents and Chemotherapy, 1998
- Repeated and persistent infection with Chlamydia and the development of chronic inflammation and diseaseTrends in Microbiology, 1994